ELI LILLY & Co — Director's Dealing 2025

Jun 6, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-06-01

Reporting Person: Custer Kenneth L. (EVP & President, Card Met Hlth)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9328.82	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2026-11-01	Common Stock (3220)		Direct
Restricted Stock Unit	$	2026-02-16	Common Stock (207)		Direct
Restricted Stock Unit	$	2027-02-16	Common Stock (209)		Direct
Restricted Stock Unit	$	2028-02-16	Common Stock (177.045)		Direct
Phantom Stock	$		Common Stock (1557.32)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: Shares of phantom stock are payable in cash following termination of the reporting person's employment with Eli Lilly and Company. The reporting person may transfer his phantom stock account into an alternative investment account at any time.

F3: Each share of phantom stock represents the right to receive the cash value of one share of Eli Lilly and Company common stock.